Evidence map›Paper›PMID 37235189›Full record

ArticleChemical & biomedical imaging2023

Water-Soluble Gd(III)-Porphyrin Complexes Capable of Both Photosensitization and Relaxation Enhancement.

Tamas Nemeth, Naoko Yoshizawa-Sugata, Agnes Pallier, Youichi Tajima, Yue Ma, Éva Tóth, Hisao Masai, Yoko Yamakoshi

Abstract read
In one paragraph

Article in Chemical & biomedical imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tamas NemethDepartment of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 3, CH8093 Zürich, Switzerland.ORCID https://orcid.org/0000-0003-4739-5882
Naoko Yoshizawa-SugataResearch Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan.ORCID https://orcid.org/0000-0001-8792-8669
Agnes PallierCentre de Biophysique Moléculaire, CNRS UPR 4301, University of Orléans, Rue Charles Sadron, 45071 Cedex 2 Orléans, France.
Youichi TajimaDepartment of Basic Medical Sciences, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan.ORCID https://orcid.org/0000-0002-9597-7054
Yue MaDepartment of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 3, CH8093 Zürich, Switzerland.ORCID https://orcid.org/0000-0002-6476-3715
Éva TóthCentre de Biophysique Moléculaire, CNRS UPR 4301, University of Orléans, Rue Charles Sadron, 45071 Cedex 2 Orléans, France.
Hisao MasaiDepartment of Basic Medical Sciences, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan.ORCID https://orcid.org/0000-0003-1268-5302
Yoko YamakoshiDepartment of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 3, CH8093 Zürich, Switzerland.ORCID https://orcid.org/0000-0001-8466-0118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the aim of developing more stable Gd(III)-porphyrin complexes, two types of ligands

Identifiers

PMID37235189
PMCPMC10207321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.